Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tianshu capsule for migraine with blood stasis obstruction pattern
ChiCTR2300078588Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Tianshu in migraine (5 arms), sponsored by Beijing University of Chinese Medicine. Primary endpoint: Change from baseline in migraine attack frequency after 12 weeks. Started Oct 2023; status: recruiting.
02
Drugs
Tianshu
03
Conditions
migraine
Beyond the preview
Go deeper on ChiCTR2300078588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078588.